{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:41:57Z","timestamp":1790757717704,"version":"4.1.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["Z01-C-004020"],"award-info":[{"award-number":["Z01-C-004020"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01838","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:12:16Z","timestamp":1534291936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":126,"title":["Tissue-Specific Roles of NKT Cells in Tumor Immunity"],"prefix":"10.3389","volume":"9","author":[{"given":"Masaki","family":"Terabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Berzofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B5","first-page":"195","article-title":"Development and selection of Valpha l4i NKT cells","volume":"314","author":"MacDonald","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.coi.2008.03.018","article-title":"CD1d-restricted iNKT cells, the \u2018Swiss-Army knife\u2019 of the immune system","volume":"20","author":"Matsuda","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0065-230X(08)00408-9","article-title":"The role of NKT cells in tumor immunity","volume":"101","author":"Terabe","year":"2008","journal-title":"Adv Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1073\/pnas.1332805100","article-title":"Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.20030630","article-title":"Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function","volume":"198","author":"Stetson","year":"2003","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8708","DOI":"10.1073\/pnas.83.22.8708","article-title":"Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma","volume":"83","author":"Imai","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/intimm\/1.6.557","article-title":"Predominant use of a particular alpha-chain in suppressor T cell hybridomas specific for keyhole limpet hemocyanin","volume":"1","author":"Koseki","year":"1989","journal-title":"Int Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.178.1.1","article-title":"Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain","volume":"178","author":"Porcelli","year":"1993","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.180.3.1171","article-title":"An invariant V alpha 24-J alpha Q\/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells","volume":"180","author":"Dellabona","year":"1994","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1084\/jem.180.3.1097","article-title":"An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans","volume":"180","author":"Lantz","year":"1994","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/intimm\/7.7.1157","article-title":"Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations","volume":"7","author":"Makino","year":"1995","journal-title":"Int Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","article-title":"Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors","volume":"278","author":"Cui","year":"1997","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1084\/jem.182.4.993","article-title":"CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice","volume":"182","author":"Cardell","year":"1995","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4049\/jimmunol.165.1.168","article-title":"CD1d-specific NK1.1+ T cells with a transgenic variant TCR","volume":"165","author":"Skold","year":"2000","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1084\/jem.191.11.1895","article-title":"In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers","volume":"191","author":"Benlagha","year":"2000","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1084\/jem.192.5.741","article-title":"Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers","volume":"192","author":"Matsuda","year":"2000","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1073\/pnas.051604498","article-title":"Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography","volume":"98","author":"Karadimitris","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1084\/jem.20051381","article-title":"A nonclassical non-Va14Ja18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance","volume":"202","author":"Terabe","year":"2005","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.20031389","article-title":"Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide","volume":"199","author":"Jahng","year":"2004","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1084\/jem.20051625","article-title":"Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity","volume":"202","author":"Zajonc","year":"2005","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1172\/JCI31602","article-title":"Type II NK T cell-mediated anergy induction in type I NK T cells prevents inflammatory liver disease","volume":"117","author":"Halder","year":"2007","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fimmu.2018.00314","article-title":"Possible therapeutic application of targeting type II natural killer T cell-mediated suppression of tumor immunity","volume":"9","author":"Kato","year":"2018","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1084\/jem.20011786","article-title":"Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining","volume":"195","author":"Gumperz","year":"2002","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20011908","article-title":"Distinct functional lineages of human Va24 natural killer cells","volume":"195","author":"Lee","year":"2002","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1073\/pnas.0801631105","article-title":"Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population","volume":"105","author":"Coquet","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1001255","DOI":"10.1371\/journal.pbio.1001255","article-title":"Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines","volume":"10","author":"Watarai","year":"2012","journal-title":"PLoS Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/QCO.0000000000000180","article-title":"The pregnant healthcare worker: fact and fiction","volume":"28","author":"Lynch","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ni.2731","article-title":"Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells","volume":"14","author":"Lee","year":"2013","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","article-title":"Tissue-specific distribution of iNKT cells impacts their cytokine response","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1172\/JCI72308","article-title":"IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset","volume":"124","author":"Sag","year":"2014","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ni.3047","article-title":"Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue","volume":"16","author":"Lynch","year":"2015","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ni.2172","article-title":"Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner","volume":"13","author":"King","year":"2011","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ni.2166","article-title":"Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses","volume":"13","author":"Chang","year":"2012","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4049\/jimmunol.1102281","article-title":"Rapamycin combined with TGF-beta converts human invariant NKT cells into suppressive Foxp3+ regulatory cells","volume":"188","author":"Moreira-Teixeira","year":"2012","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nature03407","article-title":"Recognition of bacterial glycosphingolipids by natural killer T cells","volume":"434","author":"Kinjo","year":"2005","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature03408","article-title":"Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections","volume":"434","author":"Mattner","year":"2005","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/eji.200526157","article-title":"Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells","volume":"35","author":"Sriram","year":"2005","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ni1380","article-title":"Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria","volume":"7","author":"Kinjo","year":"2006","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ni1002","article-title":"Mechanism of CD1d-restricted natural killer T cell activation during microbial infection","volume":"4","author":"Brigl","year":"2003","journal-title":"Nat Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.1400722","article-title":"Antigen-dependent versus -independent activation of invariant NKT cells during infection","volume":"192","author":"Holzapfel","year":"2014","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1084\/jem.188.10.1831","article-title":"Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes","volume":"188","author":"Lehuen","year":"1998","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nm0901-1057","article-title":"Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes","volume":"7","author":"Sharif","year":"2001","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nri1028","article-title":"Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity","volume":"3","author":"Wilson","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/82698","article-title":"NKT cells and tumor immunity \u2013 a double-edged sword","volume":"1","author":"Smyth","year":"2000","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.4049\/jimmunol.180.6.3627","article-title":"NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis","volume":"180","author":"Berzofsky","year":"2008","journal-title":"J Immunol"},{"key":"B55","first-page":"529","article-title":"KRN7000, a novel immunomodulator, and its antitumor activities","volume":"7","author":"Kobayashi","year":"1995","journal-title":"Oncol Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J Med Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1248\/bpb.18.1487","article-title":"Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties","volume":"18","author":"Motoki","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"B58","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.163.5.2387","article-title":"Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide","volume":"163","author":"Toura","year":"1999","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1084\/jem.20031192","article-title":"Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide","volume":"198","author":"Schmieg","year":"2003","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1182\/blood.V99.4.1259","article-title":"Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide","volume":"99","author":"Smyth","year":"2002","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1084\/jem.20042280","article-title":"Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer","volume":"201","author":"Smyth","year":"2005","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.4049\/jimmunol.165.5.2665","article-title":"The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent","volume":"165","author":"Smyth","year":"2000","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/intimm\/12.6.909","article-title":"Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12","volume":"12","author":"Takeda","year":"2000","journal-title":"Int Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4049\/jimmunol.170.3.1197","article-title":"The contribution of NKT cells, NK cells, and other gamma-chain-dependent non-T non-B cells to IL-12-mediated rejection of tumors","volume":"170","author":"Park","year":"2003","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.189.7.1121","article-title":"The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells","volume":"189","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1084\/jem.20030324","article-title":"Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein","volume":"198","author":"Fujii","year":"2003","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1084\/jem.20020092","article-title":"A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas","volume":"196","author":"Crowe","year":"2002","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J Exp Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1073\/pnas.1834479100","article-title":"CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses","volume":"100","author":"Nishikawa","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B72","first-page":"5102","article-title":"Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells","volume":"59","author":"Kawano","year":"1999","journal-title":"Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.4049\/jimmunol.1001018","article-title":"Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95\/CD178-dependent and is correlated with antigenic potency","volume":"185","author":"Wingender","year":"2010","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","article-title":"Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells","volume":"163","author":"Carnaud","year":"1999","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","article-title":"Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells","volume":"167","author":"Metelitsa","year":"2001","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI42314","article-title":"Mouse and human iNKT cell agonist beta-mannosylceramide reveals a distinct mechanism of tumor immunity","volume":"121","author":"O\u2019Konek","year":"2011","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1158\/1078-0432.CCR-12-2169","article-title":"Beta-mannosylceramide activates type I natural killer T cells to induce tumor immunity without inducing long-term functional anergy","volume":"19","author":"O\u2019Konek","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.4049\/jimmunol.1302623","article-title":"alpha-galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2\/3","volume":"192","author":"Huang","year":"2014","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"17275","DOI":"10.1073\/pnas.1114255108","article-title":"Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy","volume":"108","author":"Wu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1084\/jem.20021650","article-title":"A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-05-0877","article-title":"Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas","volume":"11","author":"Tachibana","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1200\/JCO.2006.08.5787","article-title":"Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma","volume":"25","author":"Molling","year":"2007","journal-title":"J Clin Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1046\/j.1423-0410.2002.00217.x","article-title":"Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells","volume":"83","author":"Okai","year":"2002","journal-title":"Vox Sang"},{"key":"B85","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","article-title":"Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity","volume":"103","author":"Nieda","year":"2004","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","article-title":"A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1158\/1078-0432.CCR-06-0114","article-title":"A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer","volume":"12","author":"Motohashi","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B88","first-page":"169","article-title":"Clinical trials of invariant natural killer T cell-based immunotherapy for cancer","volume-title":"Natural Killer T Cells: Balancing the Regulation of Tumor Immunity","author":"Motohashi","year":"2011"},{"key":"B89","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fimmu.2013.00409","article-title":"NKT cells as an ideal anti-tumor immunotherapeutic","volume":"4","author":"Fujii","year":"2013","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/82771","article-title":"NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway","volume":"1","author":"Terabe","year":"2000","journal-title":"Nat Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20022227","article-title":"Transforming growth factor-b production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence","volume":"198","author":"Terabe","year":"2003","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1158\/0008-5472.CAN-07-5301","article-title":"Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2","volume":"68","author":"Fichtner-Feigl","year":"2008","journal-title":"Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.4049\/jimmunol.165.11.6015","article-title":"Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma","volume":"165","author":"Ostrand-Rosenberg","year":"2000","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.4049\/jimmunol.169.10.5796","article-title":"Resistance to metastatic disease in Stat6-deficient mice requires hematopoietic and non-hematopoietic cells and is IFNg-dependent","volume":"169","author":"Ostrand-Rosenberg","year":"2002","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1158\/0008-5472.CAN-05-3421","article-title":"CD1d-restricted NKT cells can down-regulate tumor immunosurveillance independent of IL-4R-STAT6 or TGF-\u00df","volume":"66","author":"Terabe","year":"2006","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1182\/blood-2007-05-092866","article-title":"Type I NKT cells protect (and type II NKT cells suppress) the host\u2019s innate antitumor immune response to a B-cell lymphoma","volume":"111","author":"Renukaradhya","year":"2008","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/imm.12353","article-title":"Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-beta\/Smad signalling pathway","volume":"143","author":"Bailey","year":"2014","journal-title":"Immunology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1158\/1078-0432.CCR-09-1066","article-title":"Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody","volume":"15","author":"Terabe","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ijc.24961","article-title":"Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells","volume":"126","author":"Takaku","year":"2010","journal-title":"Int J Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e1308616","DOI":"10.1080\/2162402X.2017.1308616","article-title":"Blockade of only TGF-\u03b2 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy","volume":"6","author":"Terabe","year":"2017","journal-title":"Oncoimmunology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"B104","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00262-015-1653-0","article-title":"Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)","volume":"64","author":"Lacouture","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"B105","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.4049\/jimmunol.179.8.5126","article-title":"Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis","volume":"179","author":"Ambrosino","year":"2007","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.it.2007.05.008","article-title":"NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis","volume":"28","author":"Terabe","year":"2007","journal-title":"Trends Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1517\/14712598.8.6.725","article-title":"Regulation of tumor immunity: the role of NKT cells","volume":"8","author":"Ambrosino","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00262-008-0495-4","article-title":"A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity","volume":"57","author":"Berzofsky","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"B109","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00262-013-1509-4","article-title":"The immunoregulatory role of type I and type II NKT cells in cancer and other diseases","volume":"63","author":"Terabe","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"B110","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0065-2776(08)60652-5","article-title":"Heterogeneity of cytokine secretion patterns and functions of helper T cells","volume":"46","author":"Mosmann","year":"1989","journal-title":"Adv Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.coi.2018.03.009","article-title":"Plasticity of myeloid-derived suppressor cells in cancer","volume":"51","author":"Tcyganov","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.4049\/jimmunol.0802430","article-title":"Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine","volume":"182","author":"Ko","year":"2009","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1084\/jem.20040317","article-title":"The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80\/86 costimulation","volume":"199","author":"Fujii","year":"2004","journal-title":"J Exp Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4049\/jimmunol.1100502","article-title":"Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse","volume":"187","author":"Kmieciak","year":"2011","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","article-title":"Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10","volume":"193","author":"Huang","year":"2014","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/ni.1942","article-title":"Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A","volume":"11","author":"De Santo","year":"2010","journal-title":"Nat Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1172\/JCI37869","article-title":"Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages","volume":"119","author":"Song","year":"2009","journal-title":"J Clin Invest"},{"key":"B119","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.gastro.2012.04.017","article-title":"Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice","volume":"143","author":"Wingender","year":"2012","journal-title":"Gastroenterology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4049\/jimmunol.175.2.899","article-title":"NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii","volume":"175","author":"Ronet","year":"2005","journal-title":"J Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1182\/blood-2009-03-211441","article-title":"TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors","volume":"114","author":"Kohrt","year":"2009","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/hep.22761","article-title":"Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice","volume":"49","author":"Santodomingo-Garzon","year":"2009","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1172\/JCI44845","article-title":"Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity","volume":"121","author":"Chang","year":"2011","journal-title":"J Clin Invest"},{"key":"B125","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1084\/jem.20101692","article-title":"Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay","volume":"208","author":"Diana","year":"2011","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/mi.2017.34","article-title":"Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells","volume":"11","author":"Wang","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.4049\/jimmunol.1300562","article-title":"Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells","volume":"191","author":"Venken","year":"2013","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/icb.2010.9","article-title":"Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand","volume":"88","author":"Petersen","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/icb.2012.58","article-title":"Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells","volume":"91","author":"Mattarollo","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1158\/0008-5472.CAN-12-2567","article-title":"Delicate balance among three types of T cells in concurrent regulation of tumor immunity","volume":"73","author":"Izhak","year":"2013","journal-title":"Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00432-012-1251-x","article-title":"Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia","volume":"138","author":"Najera Chuc","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.4049\/jimmunol.167.7.4046","article-title":"Loss of IFN-gamma production by invariant NK T cells in advanced cancer","volume":"167","author":"Tahir","year":"2001","journal-title":"J Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.4049\/jimmunol.168.12.6494","article-title":"Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide","volume":"168","author":"Yanagisawa","year":"2002","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4049\/jimmunol.171.10.5631","article-title":"NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells","volume":"171","author":"Kenna","year":"2003","journal-title":"J Immunol"},{"key":"B135","first-page":"4101","article-title":"Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells","volume":"63","author":"van der Vliet","year":"2003","journal-title":"Cancer Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e24211","DOI":"10.4161\/onci.24211","article-title":"Balance is a key for happiness","volume":"2","author":"Izhak","year":"2013","journal-title":"Oncoimmunology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.1219328","article-title":"Microbial exposure during early life has persistent effects on natural killer T cell function","volume":"336","author":"Olszak","year":"2012","journal-title":"Science"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e30568","DOI":"10.1371\/journal.pone.0030568","article-title":"Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance","volume":"7","author":"Satoh","year":"2012","journal-title":"PLoS One"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e1439305","DOI":"10.1080\/2162402X.2018.1439305","article-title":"Differential regulation of T-cell mediated anti-tumor memory and cross-protection against the same tumor in lungs versus skin","volume":"7","author":"O\u2019Konek","year":"2018","journal-title":"Oncoimmunology"},{"key":"B140","doi-asserted-by":"publisher","first-page":"172ra120","DOI":"10.1126\/scitranslmed.3004888","article-title":"Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors","volume":"5","author":"Sandoval","year":"2013","journal-title":"Sci Transl Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"15221","DOI":"10.1038\/ncomms15221","article-title":"Induction of resident memory T cells enhances the efficacy of cancer vaccine","volume":"8","author":"Nizard","year":"2017","journal-title":"Nat Commun"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.4049\/jimmunol.0903231","article-title":"Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model","volume":"185","author":"Bourquin","year":"2010","journal-title":"J Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.4049\/jimmunol.1402711","article-title":"CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients","volume":"194","author":"Djenidi","year":"2015","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.juro.2015.02.2941","article-title":"CD103+ tumor infiltrating lymphocytes predict a favorable prognosis in urothelial cell carcinoma of the bladder","volume":"194","author":"Wang","year":"2015","journal-title":"J Urol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fimmu.2016.00573","article-title":"Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients","volume":"7","author":"Murray","year":"2016","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ni.3775","article-title":"Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer","volume":"18","author":"Ganesan","year":"2017","journal-title":"Nat Immunol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.18632\/oncotarget.14632","article-title":"Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma","volume":"8","author":"Koh","year":"2017","journal-title":"Oncotarget"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1338230","DOI":"10.1080\/2162402X.2017.1338230","article-title":"CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer","volume":"6","author":"Komdeur","year":"2017","journal-title":"Oncoimmunology"},{"key":"B150","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1158\/0008-5472.CAN-08-0206","article-title":"Transforming growth factor {beta} subverts the immune system into directly promoting tumor growth through interleukin-17","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-08-0215","article-title":"An anti-transforming growth factor {beta} antibody suppresses metastasis via cooperative effects on multiple cell compartments","volume":"68","author":"Nam","year":"2008","journal-title":"Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"10247","DOI":"10.1158\/0008-5472.CAN-08-1494","article-title":"Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/1078-0432.CCR-09-1067","article-title":"Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines","volume":"15","author":"Ueda","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01838\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:33:57Z","timestamp":1693809237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01838\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2018.01838"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01838","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"article-number":"1838"}}